| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10298219 | European Neuropsychopharmacology | 2005 | 4 Pages |
Abstract
Oral administration of Sumatriptan, a 5-HT1D agonist, has been associated with an anxiogenic effect in PD patients.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Daniella Amital, Leah Fostick, Yehuda Sasson, Seth Kindler, Howard Amital, Joseph Zohar,